Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort study
Renée Schmitz(The Netherlands Cancer Institute), Marjanka K. Schmidt(University of Cambridge), Yat-Hee Liu(The Netherlands Cancer Institute), Michael Schaapveld(The Netherlands Cancer Institute), Danalyn Byng(Duke University), Jelle Wesseling(Leiden University Medical Center), Jason K. Love(The University of Texas MD Anderson Cancer Center), Proteeti Bhattacharjee(The Netherlands Cancer Institute), Alastair M. Thompson(King's College - North Carolina), Jasmine Timbres(King's College London), Samantha M. Thomas(Duke Cancer Institute), Alexandra W. van den Belt‐Dusebout(The Netherlands Cancer Institute), Terry Hyslop(Duke Cancer Institute), Brian A. Menegaz(Baylor College of Medicine), Elinor J. Sawyer(King's College London), E. Shelley Hwang(Duke University), Karen Clements(National Health Service), Esther H. Lips(Leiden University Medical Center), Thomas R. Lynch(Duke University), Deborah Collyar(Advocates for Youth), Chiara Cresta(The Netherlands Cancer Institute), Yi Ren(Ningxia Medical University), Marc D. Ryser(University of Bern)
Cited by 44
Related Papers
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
|Nature Genetics|2013|1.1k
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
|Journal of Clinical Oncology|2021|991
Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies
|JNCI Journal of the National Cancer Institute|2010|716
Dialectical Behavior Therapy for Borderline Personality Disorder
|Annual Review of Clinical Psychology|2006|703